1. Home
  2. TOUR vs ADVM Comparison

TOUR vs ADVM Comparison

Compare TOUR & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TOUR
  • ADVM
  • Stock Information
  • Founded
  • TOUR 2006
  • ADVM 2006
  • Country
  • TOUR China
  • ADVM United States
  • Employees
  • TOUR N/A
  • ADVM N/A
  • Industry
  • TOUR Transportation Services
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • TOUR Consumer Discretionary
  • ADVM Health Care
  • Exchange
  • TOUR Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • TOUR 97.8M
  • ADVM 94.6M
  • IPO Year
  • TOUR 2014
  • ADVM 2014
  • Fundamental
  • Price
  • TOUR $0.86
  • ADVM $4.31
  • Analyst Decision
  • TOUR
  • ADVM Buy
  • Analyst Count
  • TOUR 0
  • ADVM 5
  • Target Price
  • TOUR N/A
  • ADVM $16.60
  • AVG Volume (30 Days)
  • TOUR 162.9K
  • ADVM 1.0M
  • Earning Date
  • TOUR 12-04-2025
  • ADVM 11-07-2025
  • Dividend Yield
  • TOUR 4.45%
  • ADVM N/A
  • EPS Growth
  • TOUR N/A
  • ADVM N/A
  • EPS
  • TOUR 0.03
  • ADVM N/A
  • Revenue
  • TOUR $75,532,120.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • TOUR $12.27
  • ADVM $1,191.10
  • Revenue Next Year
  • TOUR $10.18
  • ADVM N/A
  • P/E Ratio
  • TOUR $24.32
  • ADVM N/A
  • Revenue Growth
  • TOUR 7.57
  • ADVM N/A
  • 52 Week Low
  • TOUR $0.75
  • ADVM $1.78
  • 52 Week High
  • TOUR $1.18
  • ADVM $8.18
  • Technical
  • Relative Strength Index (RSI)
  • TOUR 50.07
  • ADVM 50.55
  • Support Level
  • TOUR $0.80
  • ADVM $4.18
  • Resistance Level
  • TOUR $0.86
  • ADVM $4.37
  • Average True Range (ATR)
  • TOUR 0.03
  • ADVM 0.20
  • MACD
  • TOUR 0.00
  • ADVM -0.03
  • Stochastic Oscillator
  • TOUR 80.89
  • ADVM 51.58

About TOUR Tuniu Corporation

Tuniu Corp is an online leisure travel company. The company is engaged in the provision of travel-related services in the People's Republic of China. It offers a large selection of packaged tours, including organized tours and self-guided tours, as well as travel-related services for leisure travelers. The company's organized tours provide pre-arranged itineraries, transportation, accommodations, entertainment, meals, and tour guide services. Its self-guided tours consist of combinations of flights and hotel bookings and other optional add-ons. The company derives almost all of its revenue from PRC.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: